H.B. Fuller Company

H.B. Fuller Company (FUL) Market Cap

H.B. Fuller Company has a market capitalization of $3.51B.

Financials based on reported quarter end 2026-02-28

Price: $64.43

2.01 (3.22%)

Market Cap: 3.51B

NYSE · time unavailable

CEO: Celeste Beeks Mastin

Sector: Basic Materials

Industry: Chemicals - Specialty

IPO Date: 1968-04-25

Website: https://www.hbfuller.com

H.B. Fuller Company (FUL) - Company Information

Market Cap: 3.51B · Sector: Basic Materials

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products worldwide. The company operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives. The Hygiene, Health and Consumable Adhesives segment produces and supplies specialty industrial adhesives such as, thermoplastic, thermoset, reactive, and water-based and solvent-based products for applications in various markets, including food and beverage containers, flexible packaging, consumer goods, package integrity and re-enforcement, and non-durable goods; corrugation, folding carton, tape and label, paper converting, envelopes, books, multi-wall bags, sacks, and tissue and towel; disposable diapers, feminine care, and medical garments; and health and beauty. The Engineering Adhesives segment produces and supplies high performance industrial adhesives such as reactive, light cure, two-part liquids, silicone, polyurethane, film, and fast cure products to the appliances and filters, windows, doors and wood flooring, and textile, transportation, electronics, medical, clean energy, aerospace and defense, appliance, heavy machinery, and insulating glass markets. The Construction Adhesives segment provides products used for tile setting, commercial roofing, heating, ventilation, and air conditioning and insulation applications, as well as caulks and sealants for the consumer market and professional trade. The company sells its products directly through distributors and retailers. H.B. Fuller Company was founded in 1887 and is headquartered in Saint Paul, Minnesota.

Analyst Sentiment

67%
Buy

Based on 7 ratings

Analyst 1Y Forecast: $71.00

Average target (based on 3 sources)

Consensus Price Target

Low

$63

Median

$73

High

$84

Average

$73

Potential Upside: 13.8%

Price & Moving Averages

Loading chart...

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 HB FULLER (FUL) — Investment Overview

🧩 Business Model Overview

HB Fuller (FUL) is a global formulater, manufacturer, and marketer of adhesives, sealants, and other specialty chemical products. The company serves a broad range of industrial, consumer, and construction markets worldwide, positioning itself as a critical solutions provider for bonding, sealing, and performance-enhancement needs across diverse applications. HB Fuller’s business model is built upon deep technical expertise, close customer collaboration, and continuous innovation, enabling the creation of tailored adhesive solutions that are integral to customer operations. Its scale, technical support, and global sales network underpin efficient customer reach and responsiveness, allowing the company to both defend incumbency and seize new growth opportunities across economies.

💰 Revenue Streams & Monetisation Model

HB Fuller's revenues derive from the sale of adhesive and sealant products, generated through both recurring contractual relationships and transactional purchases. The company segments its business into key end-markets including Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives. These divisions supply diverse sectors such as packaging, hygiene products, woodworking, automotive, electronics, construction, and more. The monetisation model is product-centric, with revenues typically earned on a per-unit or per-volume basis. Complementary services such as technical support, collaborative product development, and process optimisation consulting serve both as value-added offerings and differentiating features that foster stickiness and encourage long-term partnerships. Aside from direct sales, HB Fuller also accesses customers through distributors and agents in certain markets, expanding its reach and reducing go-to-market friction in fragmented geographies.

🧠 Competitive Advantages & Market Positioning

HB Fuller’s competitive moat is supported by several key factors. First, the adhesive industry demands advanced formulation capabilities and deep know-how in chemistry, positioning HB Fuller’s R&D efforts as a significant barrier to entry. Its longstanding customer relationships, often built through co-developed or custom-engineered solutions, create switching costs and solidify entrenched positions within customer supply chains. The company’s global manufacturing and distribution footprint ensures supply security and responsiveness, a critical consideration for multinational customers operating just-in-time or lean inventories. Furthermore, HB Fuller’s diversified end-market exposure limits concentration risk and helps smooth cyclicality that may afflict individual end segments. From a market positioning standpoint, HB Fuller is typically seen as a top player (generally ranking behind Henkel and Sika) in several adhesive submarkets, but possesses scale and breadth that regional or niche competitors often cannot match. Its focus on high-value, solution-based sales rather than commoditized volume business contributes to above-industry-average margins in select verticals.

🚀 Multi-Year Growth Drivers

Several durable trends support HB Fuller’s long-term growth trajectory: - **Secular Adoption of Lightweight and Sustainable Materials:** Increased use of advanced adhesives in automotive, electronics, and packaging reduces reliance on mechanical fasteners, driving content-per-unit expansion. - **Hygiene and Health Product Demand:** Demographic and lifestyle shifts globally—particularly in emerging markets—bolster consumption of hygiene products reliant on specialty adhesives. - **Green Chemistry and Regulatory Shifts:** Rising global regulatory standards for low-VOC and non-toxic adhesives require ongoing innovation, benefiting proven incumbents with advanced R&D resources. - **Geographic and End-Market Diversification:** Strategic acquisitions and organic expansion enable participation in high-growth markets and reduce exposure to economic volatility within single regions or sectors. - **Value-Added Product Innovation:** The trend towards customizable, high-performance adhesives opens opportunities for margin accretive new product development, often accompanied by long-term supply agreements and cross-selling opportunities.

⚠ Risk Factors to Monitor

Key risks associated with an investment in HB Fuller include: - **Raw Material Volatility:** Many chemical feedstocks are petroleum-derived and exhibit price volatility, creating input cost pressure that may not be immediately recoverable through pricing. - **Competitive Environment:** The adhesives industry remains highly competitive, with several global and numerous regional players vying for share, which can pressure margins if pricing discipline erodes. - **Customer Concentration and Cyclicality:** Exposure to cyclical end-markets or large customers can impact results if demand falters or customer relationships are lost for strategic or commercial reasons. - **Regulatory and Environmental Liabilities:** As a producer of chemicals, HB Fuller is subject to extensive environmental laws and product regulation, raising the risk of unforeseen compliance costs or litigation. - **Execution on Acquisition Integration:** Frequent acquisitions as part of the company’s growth strategy entail risks around integration, realization of expected synergies, and potential cultural or operational mismatches.

📊 Valuation & Market View

In evaluating HB Fuller’s valuation, typical analyst approaches include forward and trailing EBITDA and earnings multiples relative to both peers and the company’s own historical range. The company’s underlying attributes—margin stability, cash flow generation, and end-market resilience—are often reflected in premium-to-industry-average valuations, although not to the extent of faster-growing specialty chemical bellwethers. Valuation frameworks also consider free cash flow yield, reflecting the company’s capital-light nature and recurring revenue mix. The market’s key focus areas usually include the sustainability of volume growth, margin trajectories amid raw material cost shifts, and capacity for further value-accretive M&A. HB Fuller’s leverage and capital allocation policy are frequently scrutinized to assess the balance between reinvestment for growth, deleveraging, and returning capital to shareholders.

🔍 Investment Takeaway

HB Fuller occupies an attractive niche within the specialty chemicals sector, offering a blend of recurring, recession-resistant demand, diversified end-market exposure, and technological depth. Its growth prospects are propelled by innovation in high-performance applications, increasing demand for sustainable solutions, and expansion into new geographies and verticals. Meanwhile, operational discipline and portfolio management support consistent cash generation. Investors should balance these strengths against cyclicality in certain end-markets, ongoing input price volatility, integration risk from acquisitions, and the threat of intensifying competition. However, for long-term investors seeking exposure to value-added industrials with durable competitive positioning and multiple secular tailwinds, HB Fuller represents a compelling core holding.

⚠ AI-generated — informational only. Validate using filings before investing.

Fundamentals Overview

Loading fundamentals overview...

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-02-28

"FUL’s latest quarter (2026-02-28) reported Revenue of $770.8M and Net Income of $21.0M (EPS $0.38). QoQ, Revenue declined 13.9% (from $894.8M on 2025-11-29) and Net Income fell 29.2% (from $29.7M). YoY growth for Revenue and Net Income could not be calculated because the dataset does not include the same quarter last year. Over the last four quarters, profitability has weakened: net margin dropped from ~4.7% (2025-05-31) to ~7.5% (2025-08-30), then down to ~3.3% (2025-11-29) and ~2.7% (2026-02-28). Cash flow quality also deteriorated—free cash flow swung from +$59.1M (2025-11-29) to -$61.7M (2026-02-28), driven by a shift to negative operating cash flow (-$4.0M). Dividends remain steady at $0.235 per quarter (yield ~0.36%) with a payout ratio of ~0.61 in the latest period. Total shareholder returns appear modest: the stock is up 13.8% over 1 year (not >20%), and no buyback data is provided. With a consensus price target of $73.33 vs. $61.39, analyst expectations imply potential upside, partially offset by current earnings/FCF softness."

Revenue Growth

Caution

QoQ Revenue declined 13.9% (to $770.8M). YoY growth was not computable from the provided history (missing same-quarter-last-year data). Revenue has been volatile across the last four quarters (~$892–$898M in mid/late 2025, then down sharply in the latest quarter).

Profitability

Caution

Net margin contracted materially over the period: ~7.5% (2025-08-30) to ~2.7% (2026-02-28). Net Income fell 29.2% QoQ and EPS declined from $0.55 to $0.38. Over the last four quarters, profitability has deteriorated rather than expanded.

Cash Flow Quality

Neutral

Free cash flow weakened from +$59.1M (2025-11-29) to -$61.7M (2026-02-28). Operating cash flow turned negative (-$4.0M) in the latest quarter, signaling reduced earnings-to-cash conversion near-term.

Leverage & Balance Sheet

Neutral

Total assets edged up to ~$5.22B (from ~$5.13B). Equity strengthened to ~$2.07B from ~$1.88B over the last four quarters, but net debt remains high (~$1.97B), limiting resilience.

Shareholder Returns

Neutral

Stock price is up 13.79% over 1 year (moderate momentum; not >20%). Dividend yield is low (~0.36%) with dividends stable ($0.235 quarterly). Buybacks were not provided, so total return is likely understated by data limitations.

Analyst Sentiment & Valuation

Neutral

Valuation is relatively rich on the latest quarter (P/E ~42.7). However, the consensus price target (~$73.33) is above the current price ($61.39), suggesting analysts see upside despite near-term earnings/FCF softness.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Management’s prepared remarks emphasize “strong momentum” and confidence in reaching >20% EBITDA margin, supported by Q4 EBITDA margin expansion (+290 bps YoY) and adjusted EPS growth (+39%). However, the Q&A exposes near-term softness that is largely structural/seasonal rather than improving demand: Q1 revenue is guided down low single digits mainly due to Chinese New Year shifting roughly $15M–$20M revenue and $6M–$8M EBITDA from Q1 to Q2. Operationally, cash conversion remains a watch item—Quantum Leap raises working capital (Q4 net working capital 15.8% of revenue; goal <15%) and management acknowledges inventory carry. Analysts also pressed on margin assumptions: 2026 relies on continued self-help with pricing+raw benefits rising to ~$35M and ~$10M of Quantum Leap incremental savings, while volume is explicitly the swing item and HHC/BAS face continued volume softness. Overall tone is confident on EBITDA, but the undercurrent is cautious on near-term growth and free-cash-flow conversion.

AI IconGrowth Catalysts

  • Engineering Adhesives (EA) momentum excluding solar: ~7% organic growth in Q4; 5% volume growth excluding solar
  • Medical-grade adhesives platform acquisitions (GEM, Medifill) performing: revenue ~+15% vs pre-acquisition 2024; EBITDA ~+30%
  • BAS wins in LNG: CP2 project with Foster’s product for cryogenic insulation systems; LNG capacity expansion growing ~7%
  • BAS data center ramp: started shipping a large data center expected to conclude in Q4 in Texas (4 million sq ft at conclusion)
  • HHC share gains in EIMEA: gained share in Algeria and Turkey via ability to produce from new Cairo facility; packaging innovations in Asia (anti-slip coatings)
  • Fastener coating expansion via ND and subsequent acquisitions (Taiwan, Shanghai, Turkey) into a ~$0.5B fast-growing Asia/Europe market

Business Development

  • Medical-grade adhesives acquisitions: GEM and Medifill (completed early 2025) for internal indications
  • ND Industries (acquired 2024): encapsulated adhesive technology; expanded global technology/service offering
  • 3 fastener coating acquisitions (Taiwan, Shanghai, Turkey): $17M total purchase price; expected ~$3M EBITDA in 2026
  • BAS LNG project on [CP2] using Foster’s cryogenic insulation systems product
  • Notable disclosed market/tier customers: CP2 reference; CPG customers impacted by inventory behavior (no company names provided)

AI IconFinancial Highlights

  • Q4 revenue: -3.1% YoY; organic revenue: -1.3% YoY (volume -2.5%, pricing +1.2% with positive pricing in all 3 GBUs)
  • Q4 EBITDA: $170M (+15% YoY); EBITDA margin: 19% (+290 bps YoY) driven by favorable pricing, raw material cost savings, and restructuring actions
  • Adjusted gross profit margin Q4: 32.5% (+290 bps YoY)
  • Adjusted EPS Q4: $1.28 (+39% YoY) driven by higher operating income and ~1M share repurchase in FY2025
  • Net working capital % of revenue Q4: 15.8% (+130 bps YoY)
  • Guidance 2026 revenue: flat to +2% vs 2025; organic ~flat; FX benefit ~+1% (if rates stay where they are)
  • Guidance 2026 EBITDA: $630M to $660M
  • Guidance 2026 core tax rate: 26% to 27% (vs 2025 core tax rate 25.9%)
  • Guidance 2026 adjusted EPS: $4.35 to $4.70
  • Q1 2026 revenue: down low single digits; Q1 adjusted EBITDA: $110M to $120M
  • Chinese New Year impact: 1–2 weeks revenue shifted Q1→Q2; revenue impact $15M–$20M and EBITDA impact $6M–$8M
  • Raw materials/pricing carryover: FY2025 delivered ~$30M combined price+raw benefit; carryover into 2026 ~+$25M plus scaling of sourcing reallocation raises to ~+$35M for 2026; guidance implies favorable spread across the year with margins expanding in all GBUs in 2026; timing “slightly weighted to first half” but favorable for entire year
  • Solar penalty/overhang: 2025 solar revenue ~$80M; ramps down to ~$50M by year-end; 2026 includes ~ $30M revenue reduction in first 3 quarters tied to exit of deemphasized solar product

AI IconCapital Funding

  • Share repurchase: ~1 million shares repurchased in fiscal 2025 (supported lower share count and EPS growth)
  • Net debt / adjusted EBITDA: 3.1x at year-end (down from 3.3x end of Q3; down from 3.5x end of Q1) to reduce leverage
  • Leverage target reference: still “not quite” in $2.5 to 3x range; ended FY at 3.1x
  • 2026 operating cash flow guidance: $275M to $300M
  • 2026 capital expenditures: ~$160M total (including ~$50M for Project Quantum Leap)
  • Working capital drag context: elevated working capital expected to persist near term due to Quantum Leap

AI IconStrategy & Ops

  • Quantum Leap manufacturing footprint and warehouse consolidation: ramping in 2026; drives savings (expected ~$10M incremental savings in 2026 vs 2025)
  • SAP implementation completion: end of 2025; management expects meaningful reduction in capital spend tied to SAP (~$20M annually reduced dramatically)
  • Inventory/day improvements target: Quantum Leap expected to improve days on hand by ~5 days (~$15M benefit) over time
  • Inventory carry higher as Quantum Leap progresses (cash conversion below historic averages)

AI IconMarket Outlook

  • 2026 macro stance: challenging environment similar to 2025 (geopolitical tensions, tariff uncertainty, elevated inflation/interest rates, labor constraints); management expects “no macro help” and relies on self-help (pricing, cost actions, mix)
  • Q1 2026 seasonality: Chinese New Year shifts revenue/EBITDA from Q1 into Q2
  • Segment volume outlook for 2026: EA positive volume growth despite solar headwind; HHC and BAS down slightly YoY; pricing positive in all 3 GBUs ~0.5% to 1%
  • EBITDA bridge components for 2026 vs 2025: +$35M pricing/raw; +$5M to $10M FX; +$10M Quantum Leap savings; -$10M incremental variable comp rebuild; -$20M wage and other inflation; volume is the “swing item”

AI IconRisks & Headwinds

  • BAS: difficult comp in Q4 2024 (+7%); construction environment continues to weaken; overall BAS performance impacted primarily by tough comparison and muted construction demand (no government shutdown impact per management)
  • HHC packaging/CPG: weakness from North America packaging and related CPG customers; customer inventory management drove step-down in P11/P12; affordability/lack of mobility and household formation issues weighing on the business throughout 2026
  • Labor constraints and demand softness in manufacturing backdrop (management cites 2025 environment weaker than expected)
  • Chinese New Year timing creating near-term revenue/EBITDA shift: revenue almost to nothing during holiday; bounce back in Q2
  • Solar deemphasis: $30M revenue reduction in first 3 quarters of 2026 as solar product exits (solar ramp down from ~$80M FY2025 to ~$50M by year-end)
  • Working capital drag: net working capital 15.8% in Q4; elevated above goal (<15%) expected above 15% in 2026 and possibly 2027; cash conversion pressured by higher inventory during Quantum Leap

Sentiment: MIXED

Note: This summary was synthesized by AI from the FUL Q4 2025 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
📁

SEC Filings (FUL)

© 2026 Stock Market Info — H.B. Fuller Company (FUL) Financial Profile